GE HealthCare has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Portrait Mobile, a pioneering wireless and wearable monitoring solution.
The Portrait Mobile platform facilitates continuous real-time monitoring, offering personalised insights into a patient's vital signs while enabling mobility during critical recovery stages, such as post-surgery or discharge from intensive care.
Portrait Mobile ensures precise and reliable tracking of respiration rate, a vital sign crucial for early detection of patient deterioration. The synergy between hardware and software within Portrait Mobile adapts adeptly to rapidly changing patient requirements, building upon a history of proven clinical advancements.
The platform's dual-vector respiration rate measurement technology employs an innovative algorithm tailored for mobile patients. This innovation optimises electrode placement to accurately capture continuous respiratory rates even amid shifting breathing patterns.
Continuous patient monitoring and real-time data access empower clinicians to identify deteriorations earlier than conventional periodic cheques, typically spaced 4-6 hours apart.
Wireless patient-worn sensors, coupled with a compact smartphone-sized monitor, liberate patients from traditional constraints. This newfound mobility is pivotal in enhancing outcomes and curtailing hospital stays.
